Table 1 Clinical characteristics of the populations quantified for plasma anti-HBc level. *Baseline refers to the serum levels of biomarker at 10–8 years before HBsAg seroclearance (reference point for controls). The HBV DNA levels and qHBsAg at the time of HBsAg seroclearance in s-losers were significantly lower than that in controls
Characteristics | S-loser group (n = 120) | Control group (n = 120) | P-value |
|---|---|---|---|
Sex (M/F) | 65/55 | 65/55 | 1.00 |
Age (Years) | 56.45 ± 11.45 | 56.86 ± 11.32 | 0.81 |
*Baseline HBV DNA (log10 IU/mL) | 4.79 ± 4.55 | 6.91 ± 6.70 | 0.32 |
*Baseline qHBsAg (log10 IU/mL) | 1.57 ± 1.19 | 2.76 ± 0.94 | < 0.001 |
HBV DNA at year 0 (log IU/mL) | 2.64 ± 2.57 | 6.74 ± 6.67 | 0.01 |
qHBsAg at year 0 (log10 IU/mL) | -1.15 ± 0.31 | 2.16 ± 1.03 | < 0.001 |